Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niels Pallisgaard

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Haematologica|April 29, 2022
Copy number alterations define outcome in Philadelphia chromosome-positive acute lymphoblastic leukemiaHelena Hohtari, Niels Pallisgaard, Matti Kankainen, et al.
Ugeskrift for Laeger|May 14, 2015
[New disease markers within the chronic myeloproliferative neoplasms]Morten Orebo Holmström, Lukas Frans Ocias, Klaus Kallenbach, et al.
BMJ Open|February 2, 2026
ctDNA guided immunotherapy in patients with advanced non-small cell lung cancer: a nationwide Danish, randomised, intervention study (PRELUCA-PRediction in LUng CAncer Treatment) - study protocolMichael Elmkvist Andersen, Christa Haugaard Nyhus, Weronika Maria Szejniuk, et al.
Acta Oncologica (Stockholm, Sweden)|September 12, 2022
OPTIMISE: Optimisation of treatment selection and follow-up in oligometastatic colorectal cancer - a ctDNA-guided phase II randomised approach. Study protocolLouise Bach Callesen, Torben Frøstrup Hansen, Rikke Fredslund Andersen, et al.
Acta Oncologica (Stockholm, Sweden)|September 22, 2023
ctDNA-guided adjuvant treatment after radical-intent treatment of metastatic spread from colorectal cancer-the first interim results from the OPTIMISE studyLouise Bach Callesen, Torben Frøstrup Hansen, Rikke Fredslund Andersen, et al.
Plos One|September 1, 2017
Mathematical modelling as a proof of concept for MPNs as a human inflammation model for cancer developmentMorten Andersen, Zamra Sajid, Rasmus K Pedersen, et al.
European Journal of Cancer (Oxford, England : 1990)|October 29, 2015
Clinical utility of KRAS status in circulating plasma DNA compared to archival tumour tissue from patients with metastatic colorectal cancer treated with anti-epidermal growth factor receptor therapyKaren-Lise Garm Spindler, Niels Pallisgaard, Ane Lindegaard Appelt, et al.
Blood Cancer Journal|January 19, 2019
High frequencies of circulating memory T cells specific for calreticulin exon 9 mutations in healthy individualsMorten O Holmström, Shamaila M Ahmad, Uffe Klausen, et al.
Cancer Medicine|January 29, 2020
Data-driven analysis of JAK2V617F kinetics during interferon-alpha2 treatment of patients with polycythemia vera and related neoplasmsRasmus K Pedersen, Morten Andersen, Trine A Knudsen, et al.
Endoscopy International Open|May 14, 2023
Endoscopic calcium electroporation for colorectal cancer: a phase I studyMalene Broholm, Rasmus Vogelsang, Mustafa Bulut, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Haematologica|April 29, 2022
Copy number alterations define outcome in Philadelphia chromosome-positive acute lymphoblastic leukemiaHelena Hohtari, Niels Pallisgaard, Matti Kankainen, et al.
Ugeskrift for Laeger|May 14, 2015
[New disease markers within the chronic myeloproliferative neoplasms]Morten Orebo Holmström, Lukas Frans Ocias, Klaus Kallenbach, et al.
BMJ Open|February 2, 2026
ctDNA guided immunotherapy in patients with advanced non-small cell lung cancer: a nationwide Danish, randomised, intervention study (PRELUCA-PRediction in LUng CAncer Treatment) - study protocolMichael Elmkvist Andersen, Christa Haugaard Nyhus, Weronika Maria Szejniuk, et al.
Acta Oncologica (Stockholm, Sweden)|September 12, 2022
OPTIMISE: Optimisation of treatment selection and follow-up in oligometastatic colorectal cancer - a ctDNA-guided phase II randomised approach. Study protocolLouise Bach Callesen, Torben Frøstrup Hansen, Rikke Fredslund Andersen, et al.
Acta Oncologica (Stockholm, Sweden)|September 22, 2023
ctDNA-guided adjuvant treatment after radical-intent treatment of metastatic spread from colorectal cancer-the first interim results from the OPTIMISE studyLouise Bach Callesen, Torben Frøstrup Hansen, Rikke Fredslund Andersen, et al.
Plos One|September 1, 2017
Mathematical modelling as a proof of concept for MPNs as a human inflammation model for cancer developmentMorten Andersen, Zamra Sajid, Rasmus K Pedersen, et al.
European Journal of Cancer (Oxford, England : 1990)|October 29, 2015
Clinical utility of KRAS status in circulating plasma DNA compared to archival tumour tissue from patients with metastatic colorectal cancer treated with anti-epidermal growth factor receptor therapyKaren-Lise Garm Spindler, Niels Pallisgaard, Ane Lindegaard Appelt, et al.
Blood Cancer Journal|January 19, 2019
High frequencies of circulating memory T cells specific for calreticulin exon 9 mutations in healthy individualsMorten O Holmström, Shamaila M Ahmad, Uffe Klausen, et al.
Cancer Medicine|January 29, 2020
Data-driven analysis of JAK2V617F kinetics during interferon-alpha2 treatment of patients with polycythemia vera and related neoplasmsRasmus K Pedersen, Morten Andersen, Trine A Knudsen, et al.
Endoscopy International Open|May 14, 2023
Endoscopic calcium electroporation for colorectal cancer: a phase I studyMalene Broholm, Rasmus Vogelsang, Mustafa Bulut, et al.
Pageof 7